CN105525039A - Amplification method for whole genome aiming at different enterovirus serotypes - Google Patents

Amplification method for whole genome aiming at different enterovirus serotypes Download PDF

Info

Publication number
CN105525039A
CN105525039A CN201610058066.5A CN201610058066A CN105525039A CN 105525039 A CN105525039 A CN 105525039A CN 201610058066 A CN201610058066 A CN 201610058066A CN 105525039 A CN105525039 A CN 105525039A
Authority
CN
China
Prior art keywords
primer
enterovirus
amplification
nucleotide sequence
ev1f
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610058066.5A
Other languages
Chinese (zh)
Inventor
马绍辉
张婕
刘建生
张海浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Medical Biology of CAMS and PUMC
Original Assignee
Institute of Medical Biology of CAMS and PUMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Medical Biology of CAMS and PUMC filed Critical Institute of Medical Biology of CAMS and PUMC
Priority to CN201610058066.5A priority Critical patent/CN105525039A/en
Publication of CN105525039A publication Critical patent/CN105525039A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses an amplification method for a whole genome aiming at different enterovirus serotypes. The method comprises the following steps: extracting RNA of the viruses, carrying out RT-PCR, sequencing and comparison on the VP1 area of the RNA of the viruses by adopting the universal primers 222-224 of the enteroviruses, and determining the serotypes of virus strains by utilizing a molecular biology experimental technology; and designing corresponding primers, namely, designing the primers by utilizing the conservative property of the enteroviruses 5'UTR and 3'UTR, and carrying out corresponding RT-PCR amplification, sequencing and comparison according to the above paired primers till the nucleotide sequence of the whole genome is obtained. The method provided by the invention has the advantages of high amplification speed, as well as simplicity, convenience and feasibility, the cost can be greatly reduced, and the operation is efficient and rapid.

Description

The amplification method of different enterovirus serotype full-length genome
Technical field
The invention belongs to biological technical field, be specifically related to a kind of amplification method of different enterovirus serotype full-length genome.
Background technology
Human enterovirus virus (humanenterovirus, HEV) Picornaviridae enterovirus genus is belonged to, according to current classification, enterovirus is mainly divided into four groups: Human enterovirus virus A, B, C and D group, have serotype more than 100, wherein A group comprises CA group (Coxsackievirus, CV-A) CV-A2 ~ 8, CV-A10, CV-A12, CV-A14, CV-A16 in, EV-A71, CV-A76, CV-A89-CV-A92 and CV-A119; B group comprises all echo, enteric cytopathogenic human orphan virus (echoviruses, E-) and Coxsackie B virus group (CV-B), also has CV-A9 and EV-B69, EV-B73-B75, EV-B77-88, EV-B93, EV-B97-98, EV-B100-101, EV-B106-107 and EV-B110; C group comprises CV-A1, CV-A11, CV-A13, CV-A17, CV-A19-CV-A22, CV-A24, EV-C95, EV-C96, EV-C99, EV-C102, EV-C104, EV-C105, EV-C109, EV-C116-EV-C118, Polio1-3; D group comprises EV-D68, EV-D70, EV-D94, EV-D111 and EV-D120.
Prior art obtains a viral whole genome sequence, first to be increased its VP1 gene by neutralization test or RT-PCR, specify the serotype of enterovirus, then design primer according to the nucleotide sequence of its serotype prototype-strain, a point 6-7 fragment increases respectively and checks order.This method for other viral full-length genome that increases (as mumps virus, Measles virus etc., these virus serotypes only have one) can better result be obtained, enterovirus is because serotype is numerous, nucleotide difference between different serotypes is larger, and difference is also larger between phase homologous serotype, in addition, enterovirus is ubiquity recombination event also, it is more difficult that traditional method is used for the amplification of enterovirus whole genome sequence, proliferation time often reaches 3-6 month, waste time and energy, workload is very large, costly.
Enterovirus causes various diseases as the pathogenic agent of hand foot mouth disease, viral encephalitis, myocarditis etc., it is again RNA viruses, genovariation is very fast, and existing genome amplification method can not be satisfied the demand, and is necessary very much the amplification method improving enterovirus whole genome sequence.
Summary of the invention
Technical problem to be solved by this invention is, overcomes the above defect, provides the amplification method of the different enterovirus serotype full-length genome that a kind of amplification rate is fast, method is simple.
In order to solve the above technical problem, the amplification method of different enterovirus serotype full-length genome of the present invention comprises the following steps:
(1) viral RNA is extracted, the VP1 district of enterovirus universal primer 222-224 to viral RNA is utilized to carry out RT-PCR amplification, then electrophoresis detection is carried out with sepharose, the voltage 120V of 1%, detected result with predict the outcome close, amplification gained Nucleotide object band is checked order, and carry out NCBIBLAST comparison, if enterovirus Reference Strains nucleotide sequence homology is greater than 75% in this inquiry sequence and GenBank database, namely think same serotype, namely obtain the nucleotide sequence of described virus VP 1 district gene simultaneously;
(2) conservative property of enterovirus 5 ' UTR and 3 ' UTR is utilized, a head end upstream primer EV1F(5 ' TTAAAACAGCCTGTGGGTTG3 ' is designed for enterovirus full-length genome) and a tail end downstream primer EV8R(5 ' CACCGAATGCGGAGAATTTA3 '), VP1 district actual nucleotide sequence viral according to step (1) amplification gained again, design the pairing upstream primer EV3F of a pairing downstream primer EV2R and described tail end downstream primer EV8R of a described head end upstream primer EV1F, then RT-PCR amplification is carried out with EV1F-EV2R and EV3F-EV8R respectively, its product with 1% sepharose, 120V carries out electrophoresis detection, if ultraviolet gel imaging instrument detected result has the electrophoretic band close to 2400bp with 5000bp namely to conform to expected results, amplification terminates, and check order with corresponding amplimer,
(3) check order, splice and arrange and check order, until obtain whole genome nucleotide sequence according to step (2) gained nucleotide sequence bamboo product sequencing primer.
Human enterovirus virus (HEV) is the RNA viruses of single-stranded positive, genome is about 7400bp, and only containing an open reading frame (ORF), this ORF is divided into P1, P2 and P3 tri-districts successively, wherein the Structural protein VP1 of P1 district encode viral is to VP4, composition viral capsid; P2 and P3 district is encodes nonstructural proteins 2A, 2B, 2C and 3A, 3B, 3C, 3D respectively.HEV5 ' non-coding region (UTR) is relative conservative with 3 ' non-coding region (UTR).Genotyping result is carried out consistent with neutralization test qualification result according to VP1 region sequence, high compared with other structural protein coding region with serotype dependency, and VP1 albumen is in main virus and factor of determination, it directly determines the antigenicity of virus, therefore, VP1 not only can be used as the foundation of different serotypes classification in enterovirus genus, and can be used as the classification reference do not belonged to together in Picornaviridae.
The present invention is according to the genetic traits of enterovirus own and " walking with primer " method, first carry out RT-PCR(reverse transcription polymerase chain reaction with the VP1 district of universal primer 222-224 to viral RNA) amplification, obtain the actual nucleotide sequence of described virus VP 1 district gene, again based on this, utilize the conservative property of enterovirus 5 ' UTR and 3 ' UTR, design a head end upstream primer EV1F and tail end downstream primer EV8R, again according to the VP1 district actual nucleotide sequence of amplification gained virus, design the pairing upstream primer EV3F of a pairing downstream primer EV2R and tail end downstream primer EV8R of a head end upstream primer EV1F, then RT-PCR amplification is carried out with EV1F-EV2R and EV3F-EV8R respectively, and with " walking with primer " method design sequencing primer, complete the mensuration of increased gene fragment order.The method of the invention obtains a complete enterovirus full-length genome expense and only needs 1/3rd of prior art, time also shortened to 2 weeks from original 3-6 month, and only need three RT-PCR to complete, time saving and energy saving, significantly reduce workload, efficiently can carry out the amplification of different enterovirus serotype strain, for large-scale enterovirus Molecular Epidemic Hygienic monitoring on hands of childhood provides guarantee.
Beneficial effect of the present invention: owing to employing the above technical scheme, the method of the invention has the advantages such as amplification rate is fast, amplification method is simple and easy to do, significantly reduce costs, be a kind of efficiently, the amplification method of different enterovirus serotype full-length genome fast.
Accompanying drawing explanation
Fig. 1 is enterovirus full genome of the present invention amplification schematic diagram;
Fig. 2 is the part VP1 gene electrophorogram of CV-B1, CV-B2, E-33 virus in the present invention's three embodiments;
Fig. 3 is CV-B1, CV-B2, E-33 virus other parts gene fragment electrophorogram in the present invention's three embodiments.
Embodiment
Below in conjunction with embodiment, the present invention is described in further detail.
The amplification method of a kind of different enterovirus serotype full-length genome of the present invention, said method comprising the steps of:
(1) viral RNA is extracted, the VP1 district of enterovirus universal primer 222-224 to viral RNA is utilized to carry out RT-PCR amplification, then electrophoresis detection is carried out with sepharose, the voltage 120V of 1%, detected result with predict the outcome close, amplification gained Nucleotide object band is checked order, and carry out NCBIBLAST comparison, if enterovirus Reference Strains nucleotide sequence homology is greater than 75% in this inquiry sequence and GenBank database, namely think same serotype, namely obtain the nucleotide sequence of described virus VP 1 district gene simultaneously;
(2) conservative property of enterovirus 5 ' UTR and 3 ' UTR is utilized, a head end upstream primer EV1F(5 ' TTAAAACAGCCTGTGGGTTG3 ' is designed for enterovirus full-length genome) and a tail end downstream primer EV8R(5 ' CACCGAATGCGGAGAATTTA3 '), VP1 district actual nucleotide sequence viral according to step (1) amplification gained again, design the pairing upstream primer EV3F of a pairing downstream primer EV2R and described tail end downstream primer EV8R of a described head end upstream primer EV1F, then RT-PCR amplification is carried out with EV1F-EV2R and EV3F-EV8R respectively, its product with 1% sepharose, 120V carries out electrophoresis detection, if ultraviolet gel imaging instrument detected result has the electrophoretic band close to 2400bp with 5000bp namely to conform to expected results, amplification terminates, and check order with corresponding amplimer,
(3) check order, splice and arrange and check order, until obtain whole genome nucleotide sequence according to step (2) gained nucleotide sequence bamboo product sequencing primer.
(3) check order, splice and arrange and check order, until obtain whole genome nucleotide sequence according to step (2) gained nucleotide sequence bamboo product sequencing primer.
Virus is isolated from the ight soil of clinical patient, namely after three generations's blind passage cells showed cytopathic alternatively use enterovirus, RT-PCR amplification, order-checking, comparison is carried out with enterovirus universal primer 222-224, identify the serotype of virus, gene order-checking is carried out to the virus of different serotypes.Method is: " walking with primer ", is exemplified below:
Embodiment one: for Coxsackie B virus 1(CV-B1)
(1) RT-PCR is carried out with the VP1 district of enterovirus universal primer 222 (5 ' CICCIGGIGGIAYRWACAT3 ')-224 (GCIATGYTIGGIACICAYRT) to viral RNA, then the sepharose of 1% is used, voltage 120V carries out electrophoresis detection, detected result compares with predicting the outcome, the close (see figure 2) of result, the analysis tool of carrying out similarity system design in Protein Data Bank or DNA database is enclosed within one of NCBIBLAST(American National Biotechnology Information center after order-checking, blast program can rapidly and public data storehouse carry out similarity gene comparision) comparison, this nucleotide sequence and coxsackie virus B1 homology be 92%, according to somatotype standard, can judge that this virus is as Coxsackie B virus 1(CV-B1), current amplification obtains the nucleotide sequence of this virus part VP1 gene in genome,
(2) to hold according to enterovirus genome 5' and the conservative property of 3' end, and the nucleotide sequence of part VP1 gene that step (1) obtains, design primer; Divide two sections, design primer is: EV1F-B12R(is about 2400bp), B13F-EV8R(is about 5000bp) (see table 2), take viral RNA as template, EV1F-B12R(is about 2400bp), B13F-EV8R(is about 5000bp) carry out RT-PCR amplification respectively for primer, be designated as B11 and B12 respectively, system is 30 μ l
2×stepbuffer15μl
Template5μl
dH2O7μl
Enzyme1μl
The each 1 μ l of Primer
RT-PCR optimum configurations is: 50 DEG C of 30min; 94 DEG C of 2min; (94 DEG C of 30s, 52 DEG C of 30s, 72 DEG C of 2.5min) × 35cycles(circulates), wherein B12 is 72 DEG C of needs 5min times; 72 DEG C of 10min; After terminating RT-PCR, with the sepharose of 1%, 120V carries out electrophoresis detection, and ultraviolet gel imaging instrument detected result has the electrophoretic band close to 2400bp and 5000bp, with the close (see figure 3) that predicts the outcome, can check order;
(3) check order:
The RT-PCR stoste order-checking of B11, respectively first with the order-checking of EV1F and B12R primer, and then designs primer B11r and B12F respectively according to the sequence of sequencing result and checks order;
The RT-PCR stoste order-checking of B12, respectively first with the order-checking of B13F and B18R primer, and then design primer B14F respectively according to the sequence of sequencing result, B14R, B15F, B16F, B16R and B17F check order;
Namely above sequencing result all by with after NCBIBLAST comparison, and is defined as object nucleotide sequence with the corresponding nucleotide sequence homology of CV-B1 or other enterovirus serotype is higher.
(4) nucleotide sequence that above comparison is determined is carried out splicing and be organized into complete whole genome sequence.
The part VP1 gene order (being scribed ss primer) of table 1:CV-B1
Table 2: the order-checking of using in embodiment one and amplimer
Remarks :-: position is uncertain
Embodiment two: for Coxsackie B virus 2(CV-B2)
(1) RT-PCR is carried out with the VP1 district of enterovirus universal primer 222-224 to viral RNA, then electrophoresis detection is carried out with sepharose, the voltage 120V of 1%, detected result compares with predicting the outcome, the close (see figure 2) of result, check order comparison in rear NCBIBLAST, the homology of this nucleotide sequence and CV-B2 is 92%, according to somatotype standard, can judge that this virus is as CV-B2, and obtain the nucleotide sequence of this virus part VP1 gene in genome.
(2) according to the conservative type that enterovirus genome 5' holds and 3' holds, and the nucleotide sequence of the part VP1 gene of step (1) acquisition, design primer; Divide two sections, design primer is: EV1F – B22R(is about 2400bp), B23F-EV8R(is about 5000bp) (see table 4), take viral RNA as template, EV1F-B22R(is about 2400bp), B23F-EV8R(is about 5000bp) for primer carries out RT-PCR respectively, be designated as B21 and B22 respectively, system is 30 μ l
2×stepbuffer15μl
Template5μl
dH2O7μl
Enzyme1μl
The each 1 μ l of Primer
RT-PCR optimum configurations is: 50 DEG C of 30min; 94 DEG C of 2min; Circulate in (94 DEG C of 30s, 52 DEG C of 30s, 72 DEG C of 2.5min) × 35, wherein B22 is 72 DEG C of needs 5min times; 72 DEG C of 10min; After terminating RT-PCR, with the sepharose of 1%, 120V carries out electrophoresis detection; Ultraviolet gel imaging instrument detected result has the electrophoretic band close to 2400bp and 5000bp, with predict the outcome close (Fig. 3), can check order;
(3) check order:
The RT-PCR stoste order-checking of B21, respectively first with the order-checking of EV1F and B22R primer, and then designs primer B21r and B22F respectively according to the sequence of sequencing result and checks order;
The RT-PCR stoste order-checking of B22, respectively first with the order-checking of B23F and EV8R primer, and then design primer B24R respectively according to the sequence of sequencing result, B25F, B25R and B27F1 check order;
Namely above sequencing result all by with after NCBIBLAST comparison, and is defined as object nucleotide sequence with the corresponding nucleotide sequence homology of CV-B1 or other enterovirus serotype is higher.
(4) nucleotide sequence that above comparison is determined is carried out splicing and be organized into complete whole genome sequence.
The part VP1 gene order (being scribed ss primer) of table 3:CV-B2
Order-checking used by table 4CV-B2 whole genome amplification and amplimer
Remarks :-: position is uncertain
Embodiment three: for Echo virus 33 type (E-33)
(1) RT-PCR is carried out with the VP1 district of enterovirus universal primer 222-224 to viral RNA, then electrophoresis detection is carried out with sepharose, the voltage 120V of 1%, detected result compares with predicting the outcome, the close (see figure 2) of result, check order comparison in rear NCBIBLAST, the homology of this nucleotide sequence and E-33 is 83%, according to somatotype standard, can judge that this virus is as E-33, and obtain the nucleotide sequence of this virus part VP1 gene in genome;
(2) to hold according to enterovirus genome 5' and the conservative type of 3' end, and the nucleotide sequence of part VP1 gene that step (1) obtains, design primer; Divide two sections, design primer is: EV1F – E332R(is about 2400bp), E333F-EV8R(is about 5000bp) (see table 6), take viral RNA as template, EV1F-E332R(is about 2400bp), E333F-EV8R(is about 5000bp) for primer carries out RT-PCR respectively, be designated as E331 and E332 respectively, system is 30 μ l
2×stepbuffer15μl
Template5μl
dH2O7μl
Enzyme1μl
The each 1 μ l of Primer
RT-PCR optimum configurations is: 50 DEG C of 30min; 94 DEG C of 2min; Circulate in (94 DEG C of 30s, 52 DEG C of 30s, 72 DEG C of 2.5min) × 35, wherein E332 is 72 DEG C of needs 5min times; 72 DEG C of 10min; After terminating RT-PCR, with the sepharose of 1%, 120V carries out electrophoresis detection; Ultraviolet gel imaging instrument detected result has the electrophoretic band close to 2400bp and 5000bp, with predict the outcome close (Fig. 3), can check order;
(3) check order:
The RT-PCR stoste order-checking of E331, respectively first with the order-checking of EV1F and E332R primer, and then designs primer E331R and E332F respectively according to the sequence of sequencing result and checks order;
The RT-PCR stoste order-checking of E3322, respectively first with the order-checking of E333F and EV8R primer, and then design primer E334F respectively according to the sequence of sequencing result, E335F1, E335F2, E335R and E336F check order;
Namely above sequencing result all by with after NCBIBLAST comparison, and is defined as object nucleotide sequence with the corresponding nucleotide sequence homology of CV-B1 or other enterovirus serotype is higher.
(4) nucleotide sequence that above comparison is determined is carried out splicing and be organized into complete whole genome sequence.
The part VP1 gene order (being scribed ss primer) of table 5:E-33
Order-checking used by table 6E-33 whole genome amplification and amplimer
Remarks :-: position is uncertain
These are only some embodiments of the present invention, as long as employ the above technical scheme, all should protection scope of the present invention be fallen into.

Claims (1)

1. an amplification method for different enterovirus serotype full-length genome, is characterized in that, said method comprising the steps of:
(1) viral RNA is extracted, the VP1 district of enterovirus universal primer 222-224 to viral RNA is utilized to carry out RT-PCR amplification, then electrophoresis detection is carried out with sepharose, the voltage 120V of 1%, detected result with predict the outcome close, amplification gained Nucleotide object band is checked order, and carry out NCBIBLAST comparison, if enterovirus Reference Strains nucleotide sequence homology is greater than 75% in this inquiry sequence and GenBank database, namely think same serotype, namely obtain the nucleotide sequence of described virus VP 1 district gene simultaneously;
(2) conservative property of enterovirus 5 ' UTR and 3 ' UTR is utilized, a head end upstream primer EV1F(5 ' TTAAAACAGCCTGTGGGTTG3 ' is designed for enterovirus full-length genome) and a tail end downstream primer EV8R(5 ' CACCGAATGCGGAGAATTTA3 '), VP1 district actual nucleotide sequence viral according to step (1) amplification gained again, design the pairing upstream primer EV3F of a pairing downstream primer EV2R and described tail end downstream primer EV8R of a described head end upstream primer EV1F, then RT-PCR amplification is carried out with EV1F-EV2R and EV3F-EV8R respectively, its product with 1% sepharose, 120V carries out electrophoresis detection, if ultraviolet gel imaging instrument detected result has the electrophoretic band close to 2400bp with 5000bp namely to conform to expected results, amplification terminates, and check order with corresponding amplimer,
(3) check order, splice and arrange and check order, until obtain whole genome nucleotide sequence according to step (2) gained nucleotide sequence bamboo product sequencing primer.
CN201610058066.5A 2016-01-28 2016-01-28 Amplification method for whole genome aiming at different enterovirus serotypes Pending CN105525039A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610058066.5A CN105525039A (en) 2016-01-28 2016-01-28 Amplification method for whole genome aiming at different enterovirus serotypes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610058066.5A CN105525039A (en) 2016-01-28 2016-01-28 Amplification method for whole genome aiming at different enterovirus serotypes

Publications (1)

Publication Number Publication Date
CN105525039A true CN105525039A (en) 2016-04-27

Family

ID=55767562

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610058066.5A Pending CN105525039A (en) 2016-01-28 2016-01-28 Amplification method for whole genome aiming at different enterovirus serotypes

Country Status (1)

Country Link
CN (1) CN105525039A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106967850A (en) * 2017-05-17 2017-07-21 中国医学科学院医学生物学研究所 The detection method of the type of COxsackie A groups 16 virus in hand-foot-and-mouth disease mixed infection
CN108424881A (en) * 2018-03-23 2018-08-21 中国食品药品检定研究院 One enterovirus, 68 type and its application in preparing EV-D68 type infection animals
CN110387438A (en) * 2019-07-08 2019-10-29 广东省公共卫生研究院 Multi-primers, kit and method for enterovirus high-flux sequence
CN112708698A (en) * 2020-12-25 2021-04-27 中山大学 Primer group for determining CVB3 virus whole gene sequence

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101509003A (en) * 2009-03-23 2009-08-19 深圳市第三人民医院 Sequence of enterovirns type71 genome and uses thereof
CN102226195A (en) * 2011-05-12 2011-10-26 湖南农业大学 Method for cloning viroid complete-genome sequence
CN103194475A (en) * 2013-04-17 2013-07-10 深圳市疾病预防控制中心 Enterovirus 71 infectious clone, as well as construction method and application thereof
CN105039330A (en) * 2015-04-01 2015-11-11 广东省微生物研究所 GII.4 type norovirus genome amplimer and amplification method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101509003A (en) * 2009-03-23 2009-08-19 深圳市第三人民医院 Sequence of enterovirns type71 genome and uses thereof
CN102226195A (en) * 2011-05-12 2011-10-26 湖南农业大学 Method for cloning viroid complete-genome sequence
CN103194475A (en) * 2013-04-17 2013-07-10 深圳市疾病预防控制中心 Enterovirus 71 infectious clone, as well as construction method and application thereof
CN105039330A (en) * 2015-04-01 2015-11-11 广东省微生物研究所 GII.4 type norovirus genome amplimer and amplification method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CÉCILE BARONTIA等: "Rapid next-generation sequencing of dengue, EV-A71and RSV-A viruses", 《JOURNAL OF VIROLOGICAL METHODS》 *
RIFQIYAH NUR UMAMI等: "Detection and Identification of Human Enteroviruses among Healthy Children in Antajaya, Bogor", 《JOURNAL OF BIOTECHNOLOGY RESEARCH IN TROPICAL REGION》 *
杨秀惠等: "可疑新型肠道病毒的初步研究", 《中国人兽共患病杂志》 *
肖红等: "2008-2009年广东手足口病非CA16非EV7肠道病毒株的鉴定及其VP1基因分型研究", 《中华微生物学和免疫学杂志》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106967850A (en) * 2017-05-17 2017-07-21 中国医学科学院医学生物学研究所 The detection method of the type of COxsackie A groups 16 virus in hand-foot-and-mouth disease mixed infection
CN108424881A (en) * 2018-03-23 2018-08-21 中国食品药品检定研究院 One enterovirus, 68 type and its application in preparing EV-D68 type infection animals
CN110387438A (en) * 2019-07-08 2019-10-29 广东省公共卫生研究院 Multi-primers, kit and method for enterovirus high-flux sequence
CN112708698A (en) * 2020-12-25 2021-04-27 中山大学 Primer group for determining CVB3 virus whole gene sequence

Similar Documents

Publication Publication Date Title
Park et al. Cloning and further sequence analysis of the ORF3 gene of wild-and attenuated-type porcine epidemic diarrhea viruses
Decaro et al. Hobi-like pestivirus: both biotypes isolated from a diseased animal
Xue et al. Genotyping of bovine viral diarrhea viruses from cattle in China between 2005 and 2008
Zhang et al. A new subgenotype 2.1 d isolates of classical swine fever virus in China, 2014
Wang et al. Quantitative in vivo and in vitro characterization of co-infection by two genetically distant grass carp reoviruses
CN105176984B (en) A kind of GII.17 types norovirus genome amplification primer and amplification method
Kim et al. Variations in spike glycoprotein gene of MERS-CoV, South Korea, 2015
Xie et al. Simultaneous typing of nine avian respiratory pathogens using a novel GeXP analyzer-based multiplex PCR assay
CN105525039A (en) Amplification method for whole genome aiming at different enterovirus serotypes
Doan et al. Molecular genotyping of duck hepatitis A viruses (DHAV) in Vietnam
CN105039330A (en) GII.4 type norovirus genome amplimer and amplification method
Kuta et al. Predominance of bovine viral diarrhea virus 1b and 1d subtypes during eight years of survey in Poland
Coupeau et al. In vivo and in vitro identification of a hypervariable region in Schmallenberg virus
Kaname et al. Recovery of African horse sickness virus from synthetic RNA
Wang et al. Differentiation of canine distemper virus isolates in fur animals from various vaccine strains by reverse transcription-polymerase chain reaction-restriction fragment length polymorphism according to phylogenetic relations in china
Lam et al. The recombinant origin of emerging human norovirus GII. 4/2008: intra-genotypic exchange of the capsid P2 domain
Supadej et al. Wide variety of recombinant strains of norovirus GII in pediatric patients hospitalized with acute gastroenteritis in Thailand during 2005 to 2015
Wang et al. The first complete genome sequence and pathogenicity characterization of fowl adenovirus 11 from chickens with inclusion body hepatitis in Pakistan
Yang et al. Development of a reverse genetics system for epizootic hemorrhagic disease virus and evaluation of novel strains containing duplicative gene rearrangements
CN104673937A (en) Porcine encephalomyocarditis virus nano PCR detection kit and detection method thereof
Sun et al. Phylogenetic and genome analysis of 17 novel Senecavirus A isolates in Guangdong Province, 2017
CN101713000B (en) RT-PCR detection method of ordinary rice black streaked dwarf virus (RBSDV)
Guo et al. Mosaic genome of Human Coxsackievirus A4 associated with herpangina and HFMD in Yancheng, China, 2016 and 2018
CN102212554A (en) Enterovirus type 71 (EV71) infectious clone and construction method
CN106947834B (en) Multiplex PCR method for detecting six duck susceptibility viruses

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160427

RJ01 Rejection of invention patent application after publication